Author:
Bouzidi Amel,Azizi Ahmed,Messoudi Omar,Abderrezzak Kirouani,Giovanni Vidari,Hellal Ahmed Noureddine,Patel Chirag N.
Abstract
AbstractIn recent years, due to the dramatic increase of the bacteria resistance to antibiotics and chemotherapeutic drugs, an increasing importance is given to the discovery of novel bioactive molecules, more potent than those in use. In this contest, methanol extracts of different parts of the medicinal plant Limoniastrum monopetalum (L.) Boiss. (Plumbaginaceae), widely occurring in Tunisia, were prepared to evaluate the antimicrobial and antiproliferative activities. The methanol extract of the roots showed the highest antibacterial activity against E. coli, S. aureus and E. faecalis, whereas the stem extract exhibited the highest antiproliferative effects towards a Hela cell line. Analysis of volatile fractions, using gas chromatography–mass spectrometry (GC–MS) and gas chromatography–flame ionization detector (GC–FID) techniques, led to the identification of camphor as the most abundant constituent, which represented from 84.85 to 99.48% of the methanol extracts. Multiple chromatographic separation of the methanol leaf extract afforded the flavonoid maeopsin-6-O-glucoside (S1) and a few fractions that were subjected to biological activity assays. One fraction exhibited interesting antibacterial activity against E. coli and E. faecalis (MIC values of 62.5 and 78.12 µg/mL, respectively), and antiproliferative effects against Hela and A549 cells (IC50 = 226 and 242.52 μg/mL, respectively). In addition, in silico studies indicated that maesopsin-6-O-glucoside, which was moderately active against Staphylococcus aureus, strongly interacted with the active site of the accessory gene regulator protein A (AgrA) of Staphylococcus aureus.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 83, 770–803 (2020).
2. Lahlou, M. The success of natural products in drug discovery. Pharmacol. Pharm. 4, 17–31 (2013).
3. Shu, Y. Z. Recent natural products based drug development: A pharmaceutical industry perspective. J. Nat. Prod. 61, 1053–1071 (1998).
4. Shariff, Z.U. Modern herbal therapy for common ailments. In Nature Pharmacy Series. Vol. 1. 9–84 (Spectrum Books Ltd./Nigeria in Association with Safari Books (Export) Ltd., 2001).
5. Hertog, M. G. L., Feskeens, E. J. M., Hollman, C. H., Katan, M. B. & Kromhout, D. Dietary antioxidant flavonoids and risk of coronary heart disease: De Zutphen elderly study. Lancet 342, 1007–1011 (1993).